CI-1042

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCI-1042
Drug Alias NameLontucirevDI-1520CI-1042ONYX-015
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBarrett EsophagusOropharyngeal NeoplasmsHead and Neck Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesOnyx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncOnyx Pharmaceuticals IncNational Cancer Institute +[4] 
Active IndicationsN/A
Inactive IndicationsBarrett EsophagusOropharyngeal NeoplasmsHead and Neck Neoplasms +[7] 

Other Information

ATC CodeN/A
Related LinksN/A